Pacific Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

Pacific Financial Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$164K	Sell	1,458 -5,928	-80%	-$643K	0.31%	44
2015 Q3	$747K	Buy	7,386 +597	+9%	+$71.6K	0.98%	26
2015 Q2	$835K	Sell	6,789 -3,030	-31%	-$363K	0.95%	25
2015 Q1	$1.12M	Sell	9,819 -84,435	-90%	-$9.31M	1.46%	23
2014 Q4	$9.53M	Buy	94,254 +84,135	+831%	+$8.18M	2.82%	12
2014 Q3	$923K	Buy	10,119 +10,041	+12,873%	+$881K	0.95%	16
2014 Q2	$7K	Buy	+78	New	+$6.14K	0.01%	44

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Pacific Financial Group's IBB Position: Q4 2015 in Review

Pacific Financial Group reduced its iShares Biotechnology ETF (IBB) stake by 80% in Q4 2015, selling an estimated $643K and leaving 1,458 shares worth $164K. The position accounts for 0.31% of the portfolio, ranked #44.

Pacific Financial Group first reported a position in IBB in Q2 2014 and has held it in 7 quarters since. The position peaked at $9.53M in Q4 2014. 432 funds tracked by Wall St. Rank hold IBB as of Q4 2015.

Pacific Financial Group held 1,458 shares of iShares Biotechnology ETF worth $164K as of Q4 2015.
Pacific Financial Group sold 5,928 iShares Biotechnology ETF shares in Q4 2015, an estimated $643K.
iShares Biotechnology ETF made up 0.31% of Pacific Financial Group's portfolio in Q4 2015, its #44 holding.
Pacific Financial Group first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 7 quarters since.
Pacific Financial Group's iShares Biotechnology ETF position peaked at $9.53M in Q4 2014.
432 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2015.

Based on Pacific Financial Group's 13F filing for Q4 2015, filed 22 Jan 2016.